Cyclacel Pharmaceuticals, Inc. (CYCC) is a biopharmaceutical company focused on the development of drugs for the treatment of various types of cancer and other serious diseases. The company focuses on the discovery and development of new therapeutic approaches based on the regulation of the cell cycle and apoptosis, which are key mechanisms in the pathogenesis of cancer. Their research and development programs include clinical studies and testing of new drugs targeting various types of tumors, including leukemias, lymphomas, and solid tumors. Cyclacel Pharmaceuticals, Inc. aims to bring innovative treatment options to patients with cancer and other diseases with high unmet medical needs.
Feed
There are no posts to show right now.
Używamy ciasteczek, aby ulepszyć Twoje doświadczenie na naszej stronie.
